The anion channel blocker, 4,4′-dinitrostilbene-2,2′-disulfonic acid prevents neuronal death and excitatory amino acid release during glycolysis inhibition in the hippocampus in vivo

Neuroscience

Volumn 142, Issue 4, 2006, Pages 1005-1017

  Camacho, A ^a   Montiel, T ^a   Massieu, L ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

anion channels; exocytosis; glutamate transporters; hypoglycemia; iodoacetate; neuronal death

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 4,4' DINITRO 2,2' STILBENEDISULFONIC ACID; 5 NITRO 2 (3 PHENYLPROPYL AMINO) BENZOIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ANION CHANNEL; ASPARTIC ACID DERIVATIVE; BENZOIC ACID DERIVATIVE; DIZOCILPINE; EXCITATORY AMINO ACID; GLUTAMATE TRANSPORTER; IODOACETIC ACID; PHLORETIN; PYRROLIDINE 2,4 DICARBOXYLATE; PYRROLIDINE DERIVATIVE; RILUZOLE; SODIUM CHANNEL BLOCKING AGENT; TAMOXIFEN; THREO BETA BENZYLOXYASPARTATE; UNCLASSIFIED DRUG;

AMINO ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXOCYTOSIS; GLYCOLYSIS; HIPPOCAMPUS; IN VIVO STUDY; MALE; MICRODIALYSIS; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASPARTIC ACID; BRAIN ISCHEMIA; CELL DEATH; ENERGY METABOLISM; EXCITATORY AMINO ACIDS; EXOCYTOSIS; EXTRACELLULAR FLUID; GLYCOLYSIS; HIPPOCAMPUS; MALE; MICRODIALYSIS; NERVE DEGENERATION; NITROBENZOATES; PHLORETIN; RATS; RATS, WISTAR; RILUZOLE; STILBENES; TAMOXIFEN; VESICULAR GLUTAMATE TRANSPORT PROTEINS; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 33750325864     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.07.004     Document Type: Article

References (74)

1. - currents in rat cultured astrocytes. J Physiol 572 (2006) 677-689
2. Al-Nakkash L., Iserovich P., Coca-Prados M., Yang H., and Reinach P.S. Functional and molecular characterization of a volume-activated chloride channel in rabbit corneal epithelial cells. J Membr Biol 201 (2004) 41-49
3. Antoine F.R., Wei C.I., Littell R.C., and Marshall M.R. HPLC method for analysis of free amino acids in fish using o-phthaldialdehyde precolumn derivatization. J Agric Food Chem 47 (1999) 5100-5107
4. Auer R.N. Hypoglycemic brain damage. Metab Brain Dis 19 (2004) 169-175
5. Auner B.G., O'Neill M.A., Valenta C., and Hadgraft J. Interaction of phloretin and 6-ketocholestanol with DPPC-liposomes as phospholipid model membranes. Int J Pharm 294 (2005) 149-155
6. Baker D.A., Xi Z.X., Shen H., Swanson C.J., and Kalivas P.W. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci 22 (2002) 9134-9141
7. Ballatori N., Truong A.T., Jackson P.S., Strange K., and Boyer J.L. ATP depletion and inactivation of an ATP-sensitive taurine channel by classic ion channel blockers. Mol Pharmacol 48 (1995) 472-476
8. Benveniste H., Drejer J., Schousboe A., and Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43 (1984) 1369-1374
9. Bultmann R., and Starke K. P2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol 349 (1994) 74-80
10. Butcher S.P., Sandberg M., Hagberg H., and Hamberger A. Cellular origins of endogenous amino acids released into the extracellular fluid of the rat striatum during severe insulin-induced hypoglycemia. J Neurochem 48 (1987) 722-728
11. Cavelier P., and Attwell D. Tonic release of glutamate by a DIDS-sensitive mechanism in rat hippocampal slices. J Physiol 564 (2005) 397-410
12. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
13. Contreras J.E., Sanchez H.A., Eugenin E.A., Speidel D., Theis M., Willecke K., Bukauskas F.F., Bennett M.V., and Saez J.C. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci U S A 99 (2002) 495-500
14. Dawson L.A., Djali S., Gonzales C., Vinegra M.A., and Zaleska M.M. Characterization of transient focal ischemia-induced increases in extracellular glutamate and aspartate in spontaneously hypertensive rats. Brain Res Bull 53 (2000) 767-776
15. Doble A., Hubert J.P., and Blanchard J.C. Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells. Neurosci Lett 140 (1992) 251-254
16. Drejer J., Benveniste H., Diemer N.H., and Schousboe A. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J Neurochem 45 (1985) 145-151
17. Dudel J., and Schramm M. A receptor for presynaptic glutamatergic autoinhibition is a glutamate transporter. Eur J Neurosci 18 (2003) 902-910
18. Estevez A.Y., O'Regan M.H., Song D., and Phillis J.W. Effects of anion channel blockers on hyposmotically induced amino acid release from the in vivo rat cerebral cortex. Neurochem Res 24 (1999) 447-452
19. Evanko D.S., Zhang Q., Zorec R., and Haydon P.G. Defining pathways of loss and secretion of chemical messengers from astrocytes. Glia 47 (2004) 233-240
20. Fan H.T., Morishima S., Kida H., and Okada Y. Phloretin differentially inhibits volume-sensitive and cyclic AMP-activated, but not Ca-activated, Cl(-) channels. Br J Pharmacol 133 (2001) 1096-1106
21. Foster A.C., Gill R., Kemp J.A., and Woodruff G.N. Systemic administration of MK801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain. Neurosci Lett 76 (1987) 307-311
22. Franco R., Torres-Marquez M.E., and Pasantes-Morales H. Evidence for two mechanisms of amino acid osmolyte release from hippocampal slices. Pflugers Arch 442 (2001) 791-800
23. Garcia O., and Massieu L. Strategies for neuroprotection against L-trans-2,4-pyrrolidine dicarboxylate-induced neuronal damage during energy impairment in vitro. J Neurosci Res 64 (2001) 418-428
24. Gemba T., Oshima T., and Ninomiya M. Glutamate efflux via the reversal of the sodium-dependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience 63 (1994) 789-795
25. Gill R. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Cerebrovasc Brain Metab Rev 6 (1994) 225-256
26. Haskew-Layton R.E., Mongin A.A., and Kimelberg H.K. Hydrogen peroxide potentiates volume-sensitive excitatory amino acid release via a mechanism involving Ca2+/calmodulin-dependent protein kinase II. J Biol Chem 280 (2005) 3548-3554
27. Heurteaux C., Laigle C., Blondeau N., Jarretou G., and Lazdunski M. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 137 (2006) 241-251
28. Huang Y.H., and Bergles D.E. Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol 14 (2004) 346-352
29. Kimelberg H.K., Nestor N.B., and Feustel P.J. Inhibition of release of taurine and excitatory amino acids in ischemia and neuroprotection. Neurochem Res 29 (2004) 267-274
30. Kulik A., Trapp S., and Ballanyi K. Ischemia but not anoxia evokes vesicular and Ca(2+)-independent glutamate release in the dorsal vagal complex in vitro. J Neurophysiol 83 (2000) 2905-2915
31. Liu L., and Chander A. Stilbene disulfonic acids inhibit synexin-mediated membrane aggregation and fusion. Biochim Biophys Acta 1254 (1995) 274-282
32. Longuemare M.C., Rose C.R., Farrell K., Ransom B.R., Waxman S.G., and Swanson R.A. K(+)-induced reversal of astrocyte glutamate uptake is limited by compensatory changes in intracellular Na+. Neuroscience 93 (1999) 285-292
33. Madl J.E., and Burgesser K. Adenosine triphosphate depletion reverses sodium-dependent, neuronal uptake of glutamate in rat hippocampal slices. J Neurosci 13 (1993) 4429-4444
34. Malcolm C.S., Benwell K.R., Lamb H., Bebbington D., and Porter R.H. Characterization of iodoacetate-mediated neurotoxicity in vitro using primary cultures of rat cerebellar granule cells. Free Radic Biol Med 28 (2000) 102-107
35. Martin D., Thompson M.A., and Nadler J.V. The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur J Pharmacol 250 (1993) 473-476
36. Massieu L., Morales-Villagran A., and Tapia R. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J Neurochem 64 (1995) 2262-2272
37. Massieu L., Gomez-Roman N., and Montiel T. In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate. Exp Neurol 165 (2000) 257-267
38. Massieu L., Thedinga K.H., McVey M., and Fagg G.E. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy. Neuroscience 55 (1993) 883-892
39. Massieu L., Haces M.L., Montiel T., and Hernandez-Fonseca K. Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. Neuroscience 120 (2003) 365-378
40. Matthews R.T., Ferrante R.J., Jenkins B.G., Browne S.E., Goetz K., Berger S., Chen I.Y., and Beal M.F. Iodoacetate produces striatal excitotoxic lesions. J Neurochem 69 (1997) 285-289
41. Mitani A., and Tanaka K. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J Neurosci 23 (2003) 7176-7182
42. Montiel T., Camacho A., Estrada-Sanchez A.M., and Massieu L. Differential effects of the substrate inhibitor l-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (dl-TBOA) of glutamate transporters on neuronal damage and extracellular amino acid levels in rat brain in vivo. Neuroscience 133 (2005) 667-678
43. Nelson R.M., Lambert D.G., Richard Green A., and Hainsworth A.H. Pharmacology of ischemia-induced glutamate efflux from rat cerebral cortex in vitro. Brain Res 964 (2003) 1-8
44. Ogata T., Nakamura Y., Tsuji K., Shibata T., and Kataoka K. A possible mechanism for the hypoxia-hypoglycemia-induced release of excitatory amino acids from cultured hippocampal astrocytes. Neurochem Res 20 (1995) 737-743
45. Olson J.E., and Martinho Jr. E. Regulation of taurine transport in rat hippocampal neurons by hypo-osmotic swelling. J Neurochem 96 (2006) 1375-1389
46. Pasantes-Morales H., Franco R., Ochoa L., and Ordaz B. Osmosensitive release of neurotransmitter amino acids: relevance and mechanisms. Neurochem Res 27 (2002) 59-65
47. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, Sydney
48. Phillis J.W., Song D., and O'Regan M.H. Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex. Brain Res 780 (1998) 352-355
49. Phillis J.W., Ren J., and O'Regan M.H. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate. Brain Res 880 (2000) 224
50. Phillis J.W., Smith-Barbour M., Perkins L.M., and O'Regan M.H. Characterization of glutamate, aspartate, and GABA release from ischemic rat cerebral cortex. Brain Res Bull 34 (1994) 457-466
51. Rossi D.J., Oshima T., and Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403 (2000) 316-321
52. Rutledge E.M., Aschner M., and Kimelberg H.K. Pharmacological characterization of swelling-induced D-[3H]aspartate release from primary astrocyte cultures. Am J Physiol 274 (1998) C1511-C1520
53. Sanchez-Carbente M.R., and Massieu L. Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J Neurochem 72 (1999) 129-138
54. Sandberg M., Nystrom B., and Hamberger A. Metabolically derived aspartate-elevated extracellular levels in vivo in lodoacetate poisoning. J Neurosci Res 13 (1985) 489-495
55. Sandberg M., Butcher S.P., and Hagberg H. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J Neurochem 47 (1986) 178-184
56. Seki Y., Feustel P.J., Keller Jr. R.W., Tranmer B.I., and Kimelberg H.K. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke 30 (1999) 433-440
57. Shimamoto K., Lebrun B., Yasuda-Kamatani Y., Sakaitani M., Shigeri Y., Yumoto N., and Nakajima T. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol 53 (1998) 195-201
58. Shulman R.G., Rothman D.L., Behar K.L., and Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci 27 (2004) 489-495
59. Singh A.K., Afink G.B., Venglarik C.J., Wang R.P., and Bridges R.J. Colonic Cl channel blockade by three classes of compounds. Am J Physiol 261 (1991) C51-C63
60. Smith S.E., and Meldrum B.S. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat. Stroke 23 (1992) 861-864
61. Sundstrom E., and Mo L.L. Mechanisms of glutamate release in the rat spinal cord slices during metabolic inhibition. J Neurotrauma 19 (2002) 257-266
62. Takagi K., Ginsberg M.D., Globus M.Y., Dietrich W.D., Martinez E., Kraydieh S., and Busto R. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology. J Cereb Blood Flow Metab 13 (1993) 575-585
63. Takahashi T., and Momiyama A. Different types of calcium channels mediate central synaptic transmission. Nature 366 (1993) 156-158
64. Tauskela J.S., Mealing G., Comas T., Brunette E., Monette R., Small D.L., and Morley P. Protection of cortical neurons against oxygen-glucose deprivation and N-methyl-D-aspartate by DIDS and SITS. Eur J Pharmacol 464 (2003) 17-25
65. Uto A., Dux E., Kusumoto M., and Hossmann K.A. Delayed neuronal death after brief histotoxic hypoxia in vitro. J Neurochem 64 (1995) 2185-2192
66. Vanden Hoek T.L., Becker L.B., Shao Z., Li C., and Schumacker P.T. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 273 (1998) 18092-18098
67. Voutsinos-Porche B., Bonvento G., Tanaka K., Steiner P., Welker E., Chatton J.Y., Magistretti P.J., and Pellerin L. Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex. Neuron 37 (2003) 275-286
68. Wallin C., Abbas A.K., Tranberg M., Weber S.G., Wigstrom H., and Sandberg M. Searching for mechanisms of N-methyl-D-aspartate-induced glutathione efflux in organotypic hippocampal cultures. Neurochem Res 28 (2003) 281-291
69. Wang S.J., Wang K.Y., and Wang W.C. Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes). Neuroscience 125 (2004) 191-201
70. Wieloch T. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 230 (1985) 681-683
71. Wong E.H., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., and Iversen L.L. The anticonvulsant MK801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A 83 (1986) 7104-7108
72. Ye Z.C., Wyeth M.S., Baltan-Tekkok S., and Ransom B.R. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J Neurosci 23 (2003) 3588-3596
73. Zeevalk G.D., Davis N., Hyndman A.G., and Nicklas W.J. Origins of the extracellular glutamate released during total metabolic blockade in the immature retina. J Neurochem 71 (1998) 2373-2381
74. Zhang J.J., Jacob T.J., Valverde M.A., Hardy S.P., Mintenig G.M., Sepulveda F.V., Gill D.R., Hyde S.C., Trezise A.E., and Higgins C.F. Tamoxifen blocks chloride channels. A possible mechanism for cataract formation. J Clin Invest 94 (1994) 1690-1697